ArticlePharmaceuticals (Basel, Switzerland)2025

3-(3-Azabicyclo[2, 2, 1]heptan-2-yl)-1,2,4-oxadiazoles as Novel Potent DPP-4 Inhibitors to Treat T2DM.

Tatiana V Zinevich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.